Retraction: Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction

, Frontiers Editorial Office

doi:10.3389/fcvm.2022.1125572

RETRACTION article

Front. Cardiovasc. Med., 04 January 2023

Sec. Atherosclerosis and Vascular Medicine

Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.1125572

Retraction: Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction

This article is a retraction of:

RETRACTED: Silencing CircHIPK3 Sponges miR-93-5p to Inhibit the Activation of Rac1/PI3K/AKT Pathway and Improves Myocardial Infarction-Induced Cardiac Dysfunction
1. Read original article

$\nFrontiers Editorial Office$ Frontiers Editorial Office^*

A Retraction of the Original Research Article
Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction

by Wu, Y., Wu, M., Yang, J., Li, Y., Peng, W., Wu, M., Yu, C., and Fang, M. (2021). Front. Cardiovasc. Med. 8:645378. doi: 10.3389/fcvm.2021.645378

The journal retracts the 30 April 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation and complete raw dataset during the investigation, which was conducted in accordance with Frontiers' policies. Given the concerns about the validity of the data and the figures, and the lack of complete raw data, the article has been retracted.

This retraction was approved by the Chief Editors of Cardiovascular Medicine and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Citation: Frontiers Editorial Office (2023) Retraction: Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction. Front. Cardiovasc. Med. 9:1125572. doi: 10.3389/fcvm.2022.1125572

Received: 16 December 2022; Accepted: 16 December 2022;
Published: 04 January 2023.

Approved by:

Masanori Aikawa, Brigham and Women's Hospital and Harvard Medical School, United States

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, yes cmVzZWFyY2guaW50ZWdyaXR5JiN4MDAwNDA7ZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.